Active Ingredient(s):Basiliximab FDA Approved: * May 12, 1998 Pharm Company: *NOVARTIS Category:Immunosuppressive
Basiliximab (trade name Simulect) is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants.
2 Mechanism of action
5 See also
6 References and notes
Basiliximab is an immunosuppressant agent used to prevent immediate transplant rejection in people who are receiving kidney transplants, in combination with o...
* May have multiple approval dates, manufacturers, or labelers.
Simulect 20 mg/5ml Intravenous Injection, Powder, for Solution